5-(Bromomethyl)-3-(4-methoxyphenyl)-1,2-oxazole, 97%, 100mg

4,4-Difluorocyclohexanol>98.0%(GC)200mg

2-Nitro-1,1'-biphenyl, 95.0%, 25g

1-(4H-1,2,4-Triazol-3-yl)piperazine, 97%, 1g

1-Bromo-4-iodo-2-(methylthio)benzene, 97%, 1g

2-Bromo-4-n-butylaniline, 93%, 25g

Colonna capillare per GC ROTI®Cap-1701 MS, 60 m, 0,25 mm, 0,25 µm, 1 Pezzo(i)

4-Bromo-1H-pyrrolo[2,3-c]pyridine, 95.0%, 100mg

5-Chloro-2,3-dimethoxybenzoic acid, 98%, 10g

(2E)-3-(4-tert-butylphenyl)-1-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

tert-Butyl-4-aminophenylacetate, 98.0%, 5g

(2S,4S,5S)-1-TERT-BUTYL 2-METHYL 4-HYDROXY-5-METHYLPYRROLIDINE-1,2-DICARBOXYLATE, 90.0%, 2g

1-(2-morpholin-4-ylethyl)-1H-pyrazol-4-amine dihydrochloride, 95.0%, 250mg